2009
Holland ML, Huston A, Noyes K. "Cost-effectiveness of testing for breast cancer susceptibility genes." Value in health : the journal of the International Society for
Pharmacoeconomics and Outcomes Research. 2009 12(2):207-16. Epub 2008 Jul 18. |
2008 Jun 1
Sharma S, Nemeth E, Chen YH, Goodnough J, Huston A, Roodman GD, Ganz T, Lichtenstein A. "Involvement of hepcidin in the anemia of multiple myeloma." Clinical cancer research : an official journal of the American
Association for Cancer Research. 2008 Jun 1; 14(11):3262-7. |
2008 Feb 1
Huston A, Leleu X, Jia X, Moreau AS, Ngo HT, Runnels J, Anderson J, Alsayed Y, Roccaro A, Vallet S, Hatjiharissi E, Tai YT, Sportelli P, Munshi N, Richardson P, Hideshima T, Roodman DG, Anderson KC, Ghobrial IM. "Targeting Akt and heat shock protein 90 produces synergistic multiple myeloma cell cytotoxicity in the bone marrow microenvironment." Clinical cancer research : an official journal of the American
Association for Cancer Research. 2008 Feb 1; 14(3):865-74. |
2006 Nov 15
Francis LK, Alsayed Y, Leleu X, Jia X, Singha UK, Anderson J, Timm M, Ngo H, Lu G, Huston A, Ehrlich LA, Dimmock E, Lentzsch S, Hideshima T, Roodman GD, Anderson KC, Ghobrial IM. "Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma." Clinical cancer research : an official journal of the American
Association for Cancer Research. 2006 Nov 15; 12(22):6826-35. |
2006 Jun
Huston A, Roodman GD. "Role of the microenvironment in multiple myeloma bone disease." Future oncology (London, England). 2006 Jun 0; 2(3):371-8. |
